Dawar Consulting
A Scientist I supports the Gene Therapy team by performing analytical characterization of lipid nanoparticles (LNPs) for gene therapy and genome editing applications. The role involves evaluating nanoparticle formulations, generating high-quality analytical data, and collaborating with cross-functional teams to advance non-viral nucleic acid delivery technologies.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Dawar Consulting.
Contract SRA / Scientist, Lipid Nanoparticle (LNP) Discovery
Addition Therapeutics
Scientist 3
Genentech
Senior Research Associate – Targeted LNP Formulation (Non-Viral Delivery)
Bristol Myers Squibb
Associate Scientist, Non Viral Delivery Technologies (Regeneron Genetics Medicines) 2
Regeneron Pharmaceuticals
Pharmaceutical Scientist (R2-R4)
Eli Lilly and Company
Associate Scientist - LNP Process Development
Eli Lilly and Company